Clinical Trial Update: A Clinical Study Evaluating Efficacy of Pirepemat on Falls Frequency in Patients with Parkinson's Disease (PD) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy of Pirepemat in reducing falls among Parkinson's disease patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Pirepemat (Pirepemat)

Snippet

Sponsor: Integrative Research Laboratories AB | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED